These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [In vitro comparison of the beta lactamase-inhibitory action of clavulanic acid and sulbactam in ampicillin-resistant enterobacteria]. Grimm H. Arzneimittelforschung; 1987 Oct; 37(10):1116-9. PubMed ID: 3501722 [Abstract] [Full Text] [Related]
7. Development of beta-lactamase inhibitors. Sutherland R. J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512 [Abstract] [Full Text] [Related]
9. Tazobactam-piperacillin compared with sulbactam-ampicillin, clavulanic acid-ticarcillin, sulbactam-cefoperazone, and piperacillin for activity against beta-lactamase-producing bacteria isolated from patients with complicated urinary tract infections. Nomura S, Hanaki H, Nagayama A. J Chemother; 1997 Apr; 9(2):89-94. PubMed ID: 9176745 [Abstract] [Full Text] [Related]
10. [In vitro activity of ampicillin and ampicillin-sulbactam on diverse bacteria]. Trucco O, Prado V, Mollinedo E, Cordoves A. Rev Med Chil; 1989 Jul; 117(7):747-54. PubMed ID: 2519428 [Abstract] [Full Text] [Related]
15. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae. Cuffini AM, de Renzi G, Tullio V, Paizis G, Carlone NA. Int J Tissue React; 1995 Jul; 17(5-6):199-203. PubMed ID: 8835630 [Abstract] [Full Text] [Related]
16. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity. Hardin TC, Butler SC, Ross S, Wakeford JH, Jorgensen JH. Pharmacotherapy; 1994 Jul; 14(2):147-52. PubMed ID: 8197032 [Abstract] [Full Text] [Related]
18. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. c. Combinations of beta-lactam antibiotics and beta-lactamases inhibitors]. Tamura M, Ito T. Nihon Rinsho; 1987 Mar; 45(3):583-7. PubMed ID: 3037135 [No Abstract] [Full Text] [Related]
19. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis. Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G. J Hyg Epidemiol Microbiol Immunol; 1991 Mar; 35(2):189-97. PubMed ID: 1940333 [Abstract] [Full Text] [Related]
20. A comparative study of the activity of first and second generation cephalosporins and their combinations with beta-lactamase inhibitors against Bacteroides fragilis. Martin MA, Liebana J, Castillo AM, Gutierrez J, Piédrola G. Microbios; 1991 Mar; 67(272-273):195-202. PubMed ID: 1779879 [Abstract] [Full Text] [Related] Page: [Next] [New Search]